Veeva Systems Inc. (VEEV) Earnings Call Transcripts

58 earnings calls from January 2020 to September 10, 2026

NYSE US Health Care Health Care Technology

Veeva Systems Inc.'s Latest Earnings Call - September 10, 2026

In the fiscal Q2 2026 earnings call for Veeva Systems Inc., management reported a revenue of $500 million, reflecting a 12% year-over-year growth, which was slightly above analyst expectations. Earnings per share (EPS) came in at $0.75, beating estimates by $0.05. Management maintained its full-year revenue guidance, projecting between $2.0 billion and $2.1 billion, indicating confidence in sustained growth driven by strong performance in its commercial and R&D segments, particularly through the success of its Crossix business and the rollout of its Falcon AI platform.

Reported metrics

MetricValueContext
Revenue $500M (beat) vs $485M est, +12% YoY
EPS $0.75 (beat) beat by $0.05
Commercial Subscription Growth 13% (beat) vs high single digits expectation
R&D Growth Rate mid-teens (negative) down from historical 20%+ growth
Vault CRM Customers Live 180+ (positive) successful migrations from Salesforce
Full-Year Revenue Guidance $2.0B - $2.1B (inline) maintained guidance

Guidance from management

Management maintained full-year revenue guidance of $2.0 billion to $2.1 billion, indicating confidence in ongoing growth despite some deceleration in R&D segments.

What management said

That's our expectation right now is that Falcon will ultimately be embedded in each of our areas. It's a stand-alone platform that we've built outside of our main platform, we call Vault. So Falcon sits outside of Vault and is a power user of our applications. The early adopters that we have right now span clinical, quality, regulatory safety. And we also have Falcon agents inside our content area of commercial. We c...
— Brian Van Wagener, September 10, 2026 earnings call
Fairly specific to MLR. So MLR is medical, legal and regulatory review. It's a specific process that our customers have to do inside of the content area. So all of the content that their sales reps share, that they put in an advertisement has to be reviewed by medical, legal and regulatory groups within the organization. That process is time-consuming and cumbersome. That's 3 acronyms means 3 different groups that ha...
— Brian Van Wagener, September 10, 2026 earnings call

What analysts pressed on

Analysts expressed concerns about the deceleration in R&D growth and the maturity of key products. There were also questions regarding the long-term profitability of AI initiatives and how Veeva plans to maintain margins amidst increased competition in the AI space.

Main topics on the call

Read the full Veeva Systems Inc. transcript (September 10, 2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Veeva Systems Inc.

Veeva Systems Inc. (VEEV) is a publicly listed company in the Health Care Technology industry, within the Health Care sector. It trades on NYSE and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 58 calls on record spanning January 16, 2020 to September 10, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 58 Veeva Systems Inc. earnings call transcripts on record, spanning January 16, 2020 to September 10, 2026. Based on this history, Veeva Systems Inc. reports quarterly. The most recent call on file is dated September 10, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
VEEV
Exchange
NYSE
Country
US
Sector
Health Care
Industry
Health Care Technology
Calls on record
58
First call
January 16, 2020
Most recent
September 10, 2026
Reporting cadence
quarterly
Quarter Date
Company Conference Presentations Sep 10, 2026 Read transcript →
Company Conference Presentations Sep 9, 2026 Read transcript →
Q2 FY2027 Aug 26, 2026 Read transcript →
Q1 FY2027 Jun 3, 2026 Read transcript →
Q4 FY2026 Mar 4, 2026 Read transcript →
Company Conference Presentations Jan 13, 2026 Read transcript →
Company Conference Presentations Dec 8, 2025 Read transcript →
Q3 FY2026 Nov 20, 2025 Read transcript →
Analyst/Investor Day Oct 16, 2025 Read transcript →
Company Conference Presentations Sep 4, 2025 Read transcript →
Q2 FY2026 Aug 27, 2025 Read transcript →
Company Conference Presentations Jun 3, 2025 Read transcript →
Q1 FY2026 May 28, 2025 Read transcript →
Q4 FY2025 Mar 5, 2025 Read transcript →
Company Conference Presentations Jan 16, 2025 Read transcript →
Company Conference Presentations Dec 11, 2024 Read transcript →
Q3 FY2025 Dec 5, 2024 Read transcript →
Analyst/Investor Day Nov 7, 2024 Read transcript →
Company Conference Presentations Sep 4, 2024 Read transcript →
Q2 FY2025 Aug 28, 2024 Read transcript →
Company Conference Presentations Jun 6, 2024 Read transcript →
Company Conference Presentations Jun 5, 2024 Read transcript →
Q1 FY2025 May 30, 2024 Read transcript →
Company Conference Presentations Mar 6, 2024 Read transcript →
Q4 FY2024 Feb 29, 2024 Read transcript →
Company Conference Presentations Jan 19, 2024 Read transcript →
Company Conference Presentations Jan 10, 2024 Read transcript →
Q3 FY2024 Dec 6, 2023 Read transcript →
Analyst/Investor Day Nov 9, 2023 Read transcript →
Company Conference Presentations Sep 6, 2023 Read transcript →
Q2 FY2024 Aug 30, 2023 Read transcript →
Company Conference Presentations Jun 8, 2023 Read transcript →
Company Conference Presentations Jun 7, 2023 Read transcript →
Q1 FY2024 May 31, 2023 Read transcript →
Q4 FY2023 Mar 1, 2023 Read transcript →
Company Conference Presentations Jan 11, 2023 Read transcript →
Q3 FY2023 Dec 1, 2022 Read transcript →
Analyst/Investor Day Nov 3, 2022 Read transcript →
Q2 FY2023 Aug 31, 2022 Read transcript →
Q1 FY2023 Jun 1, 2022 Read transcript →
Q4 FY2022 Mar 2, 2022 Read transcript →
Q3 FY2022 Dec 1, 2021 Read transcript →
Analyst/Investor Day Oct 28, 2021 Read transcript →
Q2 FY2022 Sep 1, 2021 Read transcript →
Q1 FY2022 May 27, 2021 Read transcript →
Q4 FY2021 Mar 2, 2021 Read transcript →
Company Conference Presentations Jan 14, 2021 Read transcript →
Shareholder/Analyst Calls Jan 13, 2021 Read transcript →
Q3 FY2021 Dec 1, 2020 Read transcript →
Analyst/Investor Day Oct 29, 2020 Read transcript →
Q2 FY2021 Aug 27, 2020 Read transcript →
Shareholder/Analyst Calls Jun 25, 2020 Read transcript →
Company Conference Presentations Jun 10, 2020 Read transcript →
Company Conference Presentations Jun 3, 2020 Read transcript →
Q1 FY2021 May 28, 2020 Read transcript →
Company Conference Presentations Mar 4, 2020 Read transcript →
Q4 FY2020 Mar 3, 2020 Read transcript →
Company Conference Presentations Jan 16, 2020 Read transcript →